Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy-Reference-Cited by-同舟云学术

Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy

Published:2004-03 Issue:3 Volume:58 Page:959-965
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Ang K.Kian,Andratschke Nicolaus H,Milas Luka

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference39 articles.

1. Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily;Noonberg;Drugs,2000

2. Milas L, Fan Z, Andratschke NH, et al. Epidermal growth factor receptor and tumor response to radiation: In vivo preclinical studies. Int J Radiat Oncol Biol Phys 2004;58:966–971

3. Elevated levels of transforming growth factor α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer;Grandis;Cancer Res,1993

4. Quantitative immunohistochemical analysis of transforming growth factor-α and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck;Grandis;Cancer,1996

5. Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines;Grandis;Nature Med,1996

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer;Oral Oncology;2024-07

2. Anti‑epidermal growth factor receptor monoclonal antibody therapy in locally advanced head and neck cancer: A systematic review of phase III clinical trials;Medicine International;2024-05-29

3. Insights into metastatic roadmap of head and neck cancer squamous cell carcinoma based on clinical, histopathological and molecular profiles;Molecular Biology Reports;2024-04-29

4. Comparative cytotoxicity of 177Lu on various lung cancer cells and in vivo targeting of 177Lu-labeled cetuximab;Journal of Radioanalytical and Nuclear Chemistry;2023-04-26

5. A novel 3D pillar/well array platform using patient-derived head and neck tumor to predict the individual radioresponse;Translational Oncology;2022-10